NORVIUM BIOSCIENCE Company Profile

✉ Email this page to a colleague

NORVIUM BIOSCIENCE has two hundred and thirty-nine approved drugs.

There are four US patents protecting NORVIUM BIOSCIENCE drugs. There is one tentative approval on NORVIUM BIOSCIENCE drugs.

There are fifty-one patent family members on NORVIUM BIOSCIENCE drugs in twenty-one countries and five hundred and thirty-five supplementary protection certificates in seventeen countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Norvium Bioscience	LITHIUM CARBONATE	lithium carbonate	CAPSULE;ORAL	076243-001	Jun 27, 2002		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	LETROZOLE	letrozole	TABLET;ORAL	078190-001	Dec 24, 2008		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	RABEPRAZOLE SODIUM	rabeprazole sodium	TABLET, DELAYED RELEASE;ORAL	076885-001	Nov 8, 2013		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	MINOCYCLINE HYDROCHLORIDE	minocycline hydrochloride	TABLET, EXTENDED RELEASE;ORAL	090911-001	Jul 20, 2010		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	ACYCLOVIR SODIUM	acyclovir sodium	INJECTABLE;INJECTION	203927-002	Mar 29, 2017		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Norvium Bioscience	DEMADEX	torsemide	TABLET;ORAL	020136-002	Aug 23, 1993	RE34672	⤷ Sign Up
Norvium Bioscience	ASTELIN	azelastine hydrochloride	SPRAY, METERED;NASAL	020114-001	Nov 1, 1996	5,164,194*PED	⤷ Sign Up
Norvium Bioscience	DEMADEX	torsemide	TABLET;ORAL	020136-004	Aug 23, 1993	RE30633	⤷ Sign Up
Norvium Bioscience	MENTAX	butenafine hydrochloride	CREAM;TOPICAL	020524-001	Oct 18, 1996	5,021,458	⤷ Sign Up
Norvium Bioscience	ENLON-PLUS	atropine sulfate; edrophonium chloride	INJECTABLE;INJECTION	019677-001	Nov 6, 1991	4,952,586	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Foam	2%	➤ Subscribe	2009-07-30
➤ Subscribe	Topical Foam	0.05%	➤ Subscribe	2005-06-27
➤ Subscribe	Ophthalmic Solution	0.05%	➤ Subscribe	2006-12-13
➤ Subscribe	Nasal Spray	0.125 mg base/spray	➤ Subscribe	2005-11-14
➤ Subscribe	Foam	0.12%	➤ Subscribe	2007-08-10
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03
➤ Subscribe	Inhalation Solution	0.021% and 0.042%	➤ Subscribe	2005-10-19

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
New Zealand	541526	⤷ Sign Up
Russian Federation	2381023	⤷ Sign Up
World Intellectual Property Organization (WIPO)	2004064833	⤷ Sign Up
Norway	20053577	⤷ Sign Up
European Patent Office	2289512	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0398460	SPC/GB04/032	United Kingdom	⤷ Sign Up	PRODUCT NAME: ESTRADIOL, OPTIONALLY IN THE FORM OF A HYDRATE, TOGETHER WITH DROSPIRENONE; REGISTERED: NL RVG 27505 20021211; UK PL 00053/0341 20040310
1380301	2009C/007	Belgium	⤷ Sign Up	PRODUCT NAME: DROSPIRENONE-ETHINYLESTRADIOL; AUTHORISATION NUMBER AND DATE: BE321386 20080811
0434450	1999C0033	Belgium	⤷ Sign Up	PRODUCT NAME: ABACAVIR SULFATE; NATL. REGISTRATION NO/DATE: EU/1/99/112/001 19990708; FIRST REGISTRATION: CH 55048 19990628
0325571	SPC/GB98/027	United Kingdom	⤷ Sign Up	PRODUCT NAME: TOLTERODINE OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: SE 13475 19970905; SE 13476 19970905; UK 00032/0222 19980203; UK 00032/0223 19980203
0285237	95C0008	Belgium	⤷ Sign Up	PRODUCT NAME: ESTRADIOL, HEMIHYDRATE; NAT. REGISTRATION NO/DATE: NL 19489 19941107; FIRST REGISTRATION: FR - NL 19489 19941107
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.